Compare Opal Therapeutics vs Tacere Therapeutics
Customers evaluate the quality of Opal Therapeutics's products using the following success metrics.
Overview
Opal Therapeutics is based in Australia
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Tacere Therapeutics is 18 yrs old and is based in United States.
Tacere Therapeutics, Inc. specializes in the development of both traditional and therapeutics for the treatment of Hepatitis C (HCV). Combining expertise in small molecules, gene medicine, and RNA interference (RNAi), Tacere possesses skill in the screening and identification of both pharmaceutical and biological agents for the treatment of this major unmet medical need.
Demo Video
Leadership
Stephen Kent (Founder)
Mike Catelani (President, Chief Financial Officer)
Investors
UniSeed, Alloy Ventures
Hokkaido Venture Capital and Oncolys BioPharma
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Opal Therapeutics has not claimed their profile.
Work for Opal Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Opal Therapeutics?
Claim your profile now.
Information not available because Tacere Therapeutics has not claimed their profile.
Work for Tacere Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Tacere Therapeutics?
Claim your profile now.